Glenmark launches Epinephrine injection in US
28 Feb 2025 //
ECONOMICTIMES
Veloxis Pharma`s VEL-101 Gets USAN Approval As Pegrizeprument
25 Feb 2025 //
PR NEWSWIRE
Currax Provides Update on Litigation Against Found Health
25 Feb 2025 //
PR NEWSWIRE
CivicaScript® Lowers Price of its Generic Abiraterone Tablets
24 Feb 2025 //
PR NEWSWIRE
Vanda Pharma publishes for Charcot-Marie-Tooth disease type 2S
24 Feb 2025 //
PR NEWSWIRE
Teva & Alvotech Launch Selarsdi (Ustekinumab-Aekn) In The U.S.
21 Feb 2025 //
GLOBENEWSWIRE
Orion Corp.: Disclosure Under Chapter 9 Section 10 Securities Mar
19 Feb 2025 //
GLOBENEWSWIRE
Teva Pharm CEO calls for faster US generic drug approvals
18 Feb 2025 //
REUTERS
Glenmark Pharmaceuticals launches Latanoprost Ophthalmic Solution
14 Feb 2025 //
PR NEWSWIRE
Glenmark launches generic ophthalmic solution in US market
13 Feb 2025 //
ECONOMICTIMES
Glenmark launches Clindamycin Phosphate Foam
13 Feb 2025 //
BUSINESS STD
Aurora Pharma Delivers on FDA-Approved Generic for Pain Relief
13 Feb 2025 //
PR NEWSWIRE
Disclosure Under Chapter 9 Section 10 of the Securities Market Act
12 Feb 2025 //
PRESS RELEASE
Lupin receives approval from FDA for Ipratropium Br Nasal Solution
11 Feb 2025 //
INDPHARMAPOST
Teva agrees with Axsome to keep generic off market until 2038
11 Feb 2025 //
FIERCE PHARMA
Genentech’s Gazyva Shows Superiority in Active Lupus Nephritis
07 Feb 2025 //
BUSINESSWIRE
Vaishali Pharma standalone profit declines 31.75% in Dec 2024
07 Feb 2025 //
BUSINESS STD
Lupin receives tentative FDA approval for generic Darunavir
06 Feb 2025 //
EXPRESS PHARMA
Cosette Pharma Appoints Brad as VP, Generics Commercial Operation
03 Feb 2025 //
BUSINESSWIRE
WIT Legal Releases 2nd Annual Hatch-Waxman Litigation Trends Report
03 Feb 2025 //
PR NEWSWIRE
Padagis Naloxone Becomes Lowest Priced Treatment on Amazon
03 Feb 2025 //
PR NEWSWIRE
Granules Strengthens ADHD Portfolio with FDA Approval
30 Jan 2025 //
PRESS RELEASE
A.forall Launches Tromethamine Injection With CGT Exclusivity
30 Jan 2025 //
BUSINESSWIRE
China+1 Boosts India’s Share In Pharma Beyond Generics
27 Jan 2025 //
ECONOMICTIMES
Lupin gets USFDA nod for generic HIV drug
24 Jan 2025 //
ECONOMICTIMES
Piramal Pharma launches Chlorpromazine Hydrochloride in US
23 Jan 2025 //
BUSINESS STD
Piramal Launches Chlorpromazine Hydrochloride Injection In US
23 Jan 2025 //
EXPRESSPHARMA
Sarclisa Approved In EU As 1st Anti-CD38 For Multiple Myeloma
22 Jan 2025 //
PRESS RELEASE
Sunshine Biopharma launches Olanzapine and Olanzapine ODT
22 Jan 2025 //
INDPHARMAPOST
Strides gains FDA approval for Acetaminophen and Ibuprofen
20 Jan 2025 //
EXPRESSPHARMA
China Looks Into Generic Drug Quality After Doctors Speak Up
20 Jan 2025 //
ECONOMICTIMES
Novartis wins 11th-hour bid to block Entresto generic from MSN
17 Jan 2025 //
FIERCE PHARMA
Novartis wins temporary pause to Entresto generic launch in US
16 Jan 2025 //
REUTERS
Alembic Pharma Gets USFDA Approval For Brexpiprazole Tablets
15 Jan 2025 //
EXPRESSPHARMA
Lupin launches Minzoya in the US
14 Jan 2025 //
PRESS RELEASE
Court Approves First Settlements In Generic Drug Price-Fixing Case
14 Jan 2025 //
PR NEWSWIRE
Court Approves Settlements In Generic Price Conspiracy
13 Jan 2025 //
PR NEWSWIRE
Lupin Gets Tentative U.S. FDA Approval For Ivacaftor Oral Granules
10 Jan 2025 //
EXPRESSPHARMA
Catalyst`s Teva settlement postpones arrival of Firdapse generic
09 Jan 2025 //
FIERCE PHARMA
Novo petitions FDA over Victoza compounding as generic win approval
06 Jan 2025 //
FIERCE PHARMA
Kwality Pharma gains on securing SAHPRA approval for Tamoxifen
24 Dec 2024 //
BUSINESS STD
Alembic Pharma gets USFDA nod for seizure treatment drug
20 Dec 2024 //
BUSINESS STD
Zydus gets USFDA nod for generic topical anaesthetic cream
19 Dec 2024 //
ECONOMICTIMES
Breckenridge Receives FDA Approval for Methadone HCl Injection
18 Dec 2024 //
PR NEWSWIRE
Glenmark USA launches Lacosamide Oral Solution, 10 mg/mL
18 Dec 2024 //
INDPHARMAPOST
Pharma lobby, govt meet to discuss OTC drug regulation
17 Dec 2024 //
ECONOMICTIMES
bioAffinity Technologies Hosts Live Investor Webinar on December 19
17 Dec 2024 //
BUSINESSWIRE
Granules India gets USFDA nod for ADHD Treatment
17 Dec 2024 //
PRESS RELEASE
Sandoz Resolves US Generic Drug Antitrust Litigation
17 Dec 2024 //
GLOBENEWSWIRE
Glenmark Pharma arm launches seizure drug in US
16 Dec 2024 //
BUSSINESS STD
Gland Pharma Gets FDA Approval For Phytonadione Injectable
11 Dec 2024 //
BUSINESS STD
Eugia Pharma receives FDA approval for Pazopanib Tablets, 200 mg
09 Dec 2024 //
INDPHARMAPOST
Pharma firm Teva to divest its business venture in Japan
07 Dec 2024 //
REUTERS
Lupin receives FDA tentative approval for HIV treatment generic
07 Dec 2024 //
EXPRESSPHARMA
Novartis` latest bid to block MSN`s generic comes up short
06 Dec 2024 //
FIERCE PHARMA
Auro Pharma arm gets USFDA nod for Pazopanib tabs
05 Dec 2024 //
BUSINESS STD
Alembic Pharma gets tentative USFDA nod for Olopatadine drug
04 Dec 2024 //
BUSINESS STD
Sunshine Biopharma Launches a New Generic Prescription Drug
04 Dec 2024 //
ACCESSWIRE
Gland Pharma secures FDA approval for Latanoprost Solution
03 Dec 2024 //
EXPRESSPHARMA
FDA Confirms Para IV Patent Litigation for Crextont Capsules
03 Dec 2024 //
FDA